Cocrystal Pharma (COCP) Receivables - Other (2014 - 2020)
Cocrystal Pharma (COCP) posted Receivables - Other of $556000.0 for Q4 2020, down 4.3% sequentially from $581000.0 in Q3 2020, and down 13.66% YoY from $644000.0 in Q1 2020.
Cocrystal Pharma (COCP) Receivables - Other (2014 - 2020) Analysis & Trends
Cocrystal Pharma has reported Receivables - Other for 6 years, with the latest figure at $556000.0 in Q4 2020.
- Quarterly Receivables - Other fell 13.66% year-over-year to $556000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $556000.0 (down 13.66% YoY) and the FY2020 annual result came in at $556000.0, down 13.66% from the prior year.
- Receivables - Other eased to $556000.0 in Q4 2020 per COCP's latest filing, from $581000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $1.3 million in Q4 2016 and troughed at $556000.0 in Q4 2020.
- A 4-year average of $930750.0 and a median of $841000.0 in 2019 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2016 and 2020: Receivables - Other soared 661.18% in 2016, then sank 35.23% in 2020.
- Over 4 years, Receivables - Other stood at $1.3 million in 2016, then changed by 0.0% to $1.3 million in 2017, then slumped by 50.23% to $644000.0 in 2019, then declined by 13.66% to $556000.0 in 2020.
- According to Business Quant data, Receivables - Other over the past three periods registered $556000.0, $581000.0, and $592000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 556,000.00 |
| Dec 31, 2020 | 556,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Jun 30, 2020 | 592,000.00 |
| Jun 30, 2020 | 592,000.00 |
| Mar 31, 2020 | 644,000.00 |
| Mar 31, 2020 | 644,000.00 |
| Dec 31, 2019 | 644,000.00 |
| Dec 31, 2019 | 644,000.00 |
| Sep 30, 2019 | 768,000.00 |
| Sep 30, 2019 | 768,000.00 |
| Jun 30, 2019 | 914,000.00 |
| Jun 30, 2019 | 914,000.00 |
| Dec 31, 2017 | 1.29 Mn |
| Dec 31, 2017 | 1.29 Mn |
| Sep 30, 2017 | 1.29 Mn |
| Sep 30, 2017 | 1.29 Mn |
| Jun 30, 2017 | 1.29 Mn |
| Jun 30, 2017 | 1.29 Mn |